Establishment and validation of a risk prediction model in patients with hepatocellular carcinoma treated with transarterial radioembolization

Background/aims Few studies have reported the treatment outcomes of transarterial radioembolization (TARE) using yttrium-90 ( 90 Y) for hepatocellular carcinoma (HCC). We established and validated a new risk prediction model for patients with HCC treated with TARE. Methods Between 2010 and 2017, 113 and 35 patients with intrahepatic HCC treated with TARE were selected for the training and validation cohorts, respectively. The modified response...